Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Merck KGaA (OTC: MKGAF).

Full DD Report for MKGAF

You must become a subscriber to view this report.


Recent News from (OTC: MKGAF)

MERCK KG&A (MKGAY) Presents At Citi's 2018 Global Technology Conference - Slideshow
The following slide deck was published by Merck KGaA ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 07 2018 13:29
Your Daily Pharma Scoop: Catalyst Positive, JNJ Succeeds, Blue Chips Support Tilray
Stocks in News: CBIO, JNJ Catalyst Bio's MarzAA continues to shows positive action in hemophilia study; shares up 4% premarket Discussion: Catalyst Biosciences ( CBIO ) presented updated preliminary at the Hemophilia Drug Development Summit in Boston from Phase 2/3 clinical trial asses...
Source: SeekingAlpha
Date: August, 18 2018 20:56
Merck KGaA nabs CRISPR patent in Australia
The Australian Patent Office awards a patent to Merck KGaA ( OTCPK:MKGAF )( OTCPK:MKGAY ) covering the use of paired CRISPR nickases, an approach aimed at reducing off-target effects during gene editing. More news on: Merck KGaA, Merck KGaA ADR, CRISPR Therapeutics, Healthcare stocks new...
Source: SeekingAlpha
Date: August, 15 2018 08:54
Merck KGaA (MKGAF) CEO Stefan Oschmann on Q2 2018 Results - Earnings Call Transcript
Merck KGaA (MKGAF) Q2 2018 Results Earnings Conference Call August 09, 2018 08:00 AM ET Executives Constantin Fest - IR Stefan Oschmann - Group CEO Marcus Kuhnert - CFO Udit Batra - CEO, Life Science Analysts Matt Weston - Credit Suisse Gunnar Romer - Deutsche Bank ...
Source: SeekingAlpha
Date: August, 13 2018 20:13
Merck KGaA 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Merck KGaA in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 09 2018 14:03
M & A rumor update
According to Spanish media group Interconomia, Merck KgaA ( OTCPK:MKGAF )( OTCPK:MKGAY ) will reported make a bid for Madrigal Pharmaceuticals (NASDAQ: MDGL ) next week. More news on: Merck KGaA, Merck KGaA ADR, Madrigal Pharmaceuticals, Inc., Healthcare stocks news, Merger & acquisi...
Source: SeekingAlpha
Date: July, 20 2018 07:31
MERCK KG&A (MKGAY) Performance Materials Strategy Update - Slideshow
The following slide deck was published by Merck KGaA ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: July, 03 2018 11:52
FDA withdraws draft guidance related to biosimilar development
The FDA has withdrawn its draft guidance on statistical methods to assess analytical similarity between biosimilars and reference drugs after receiving public comments and a lone citizen petition from Pharmaceutical Scientist founder Sarfaraz Niazi, an adjunct professor at the University o...
Source: SeekingAlpha
Date: July, 02 2018 12:59
Your Daily Pharma Scoop: Tetraphase Positive Data, MediWound In Phase 3, Allergan Moves Up
Analysis Focus: TTPH Tetraphase Pharma ( TTPH ) has a PDUFA on August 28 for its lead drug candidate ERAVACYCLINE in one indication - cIAI - complicated intra-abdominal infections. This PDUFA is based on an NDA filed on Feb 27 - the 6-month duration comes from a Fast Track designation; the...
Source: SeekingAlpha
Date: June, 13 2018 18:00
Merck KGaA's tepotinib successful two mid-stage liver cancer studies
Two Phase 2 clinical trials, assessing Merck KGaA's ( OTCPK:MKGAF ) tepotinib for the first-line and second-line treatment of patients with MET-positive advanced hepatocellular carcinoma (HCC) with reasonably functioning livers met the primary endpoints . More news on: Merck KGaA, Bayer A...
Source: SeekingAlpha
Date: June, 11 2018 11:17

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-10108.65109.80111.00108.65405
2018-12-07110.35108.45110.35108.45150
2018-12-06106.67106.36106.67106.361,047
2018-12-05112.50111.40112.5008111.40624
2018-12-04112.50111.40112.5008111.40624

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-04546248.6538Cover
2018-11-2820021593.0233Short
2018-11-195,5386,92879.9365Short
2018-11-1629,92532,06593.3261Short
2018-11-147017041.1765Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MKGAF.


About Merck KGaA (OTC: MKGAF)

Logo for Merck KGaA (OTC: MKGAF)

Merck KGaA is a global pharmaceutical, chemical and life science company with a history that began in and a future shaped by approximately , employees in countries. Merck KGaA s subsidiaries in North America operate using the umbrella brand EMD .

 

 

 

Current Management

  • KarlLudwig Kle Kley / CEO
  • Matthias Zachert / CFO
  • Constantin Fest / IR
  • IR Investor Relations / IR

Current Share Structure

  • Market Cap: $36,775,886,506 - 03/09/2018
  • Issue and Outstanding: 387,726,795 - 03/14/2016

 



Daily Technical Chart for (OTC: MKGAF)

Daily Technical Chart for (OTC: MKGAF)


Stay tuned for daily updates and more on (OTC: MKGAF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MKGAF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MKGAF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MKGAF and does not buy, sell, or trade any shares of MKGAF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/